Login / Signup

Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain.

Cristina AgustiHéctor Martínez RiverosÀgueda Hernández-RodríguezCristina CasañYesika Díaz RodríguezLucía AlonsoElisa MartróJordana Muñoz-BasagoitiMarçal GallemiCinta FolchIbrahim SönmezHéctor AdellMarta VillarAlexia París de LeónSandra Martínez-PucholAndreu Coello PelegrinDaniel Perez-ZsoltDàlia Raïch-ReguéRubén MoraLuis VillegasBonaventura ClotetNuria Izquierdo-UserosPere-Joan CardonaJordi Casabona
Published in: Nature communications (2023)
The recent monkeypox virus (MPXV) outbreak was of global concern and has mainly affected gay, bisexual and other men who have sex with men (GBMSM). Here we assess prevalence of MPXV in high-risk populations of GBMSM, trans women (TW) and non-binary people without symptoms or with unrecognized monkeypox (Mpox) symptoms, using a self-sampling strategy. Anal and pharyngeal swabs are tested by MPXV real-time PCR and positive samples are tested for cytopathic effect (CPE) in cell culture. 113 individuals participated in the study, 89 (78.76%) were cis men, 17 (15.04%) were TW. The median age was 35.0 years (IQR: 30.0-43.0), 96 (85.02%) individuals were gay or bisexual and 72 (63.72%) were migrants. Seven participants were MPXV positive (6.19% (95% CI: 1.75%-10.64%)). Five tested positive in pharyngeal swabs, one in anal swab and one in both. Six did not present symptoms recognized as MPXV infection. Three samples were positive for CPE, and showed anti-vaccinia pAb staining by FACS and confocal microscopy. This suggests that unrecognized Mpox cases can shed infectious virus. Restricting testing to individuals reporting Mpox symptoms may not be sufficient to contain outbreaks.
Keyphrases